V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220016793 | 220006915 | 1.84 | 80.7 | Curative (C) | 2016-06-29 | 2016-12-29 | AML 19 TRIAL | 01 | N | 220026530 | AML19 TRIAL |
| 220016794 | 220006916 | 1.61 | 49 | Curative (C) | 2017-09-20 | 2017-09-27 | AML 19 TRIAL | N | N | 220026531 | AML19 TRIAL |
| 220016795 | 220019606 | 1.71 | 54.1 | Curative (C) | 2013-11-17 | 2014-02-02 | Trial Unspecified | null | N | 220026533 | TRIAL |
| 220016796 | 220019606 | 1.72 | 81.4 | Adjuvant (A) | 2016-02-15 | 2016-02-15 | AML 19 TRIAL | Y | N | 220026533 | AML19 TRIAL |
| 220016797 | 220019606 | 1.68 | 59 | Curative (C) | null | 2018-05-11 | AML 19 TRIAL | null | N | 220026533 | AML19 TRIAL |
| 220016798 | 220006917 | 1.58 | null | Curative (C) | 2014-10-31 | 2014-10-31 | Trial Unspecified | N | N | 220026565 | TRIAL |
| 220016799 | 220013817 | 1.77 | 74.8 | Adjuvant (A) | 2017-05-13 | 2017-05-13 | AML 19 TRIAL | N | N | 220026567 | AML19 TRIAL |
| 220016800 | 220006923 | 1.72 | 105.3 | null | 2013-08-24 | 2013-08-24 | Trial Unspecified | Y | N | 220026577 | TRIAL |
| 220016801 | 220006928 | 1.61 | 68 | Palliative (P) | 2017-03-29 | 2017-03-29 | AML 19 TRIAL | Y | N | 220026587 | AML19 TRIAL |
| 220016802 | 220006932 | 1.8 | 88.95 | Not known (9) | 2014-05-24 | 2014-09-08 | Trial Unspecified | N | N | 220026595 | TRIAL |
| 220016803 | 220006934 | 1.54 | 56.6 | Curative (C) | 2016-03-30 | 2016-04-02 | AML 19 TRIAL | N | N | 220026609 | AML19 TRIAL |
| 220016804 | 220006935 | null | 81 | Curative (C) | 2017-04-15 | 2017-05-12 | AML 19 TRIAL | Y | null | 220026611 | AML19 TRIAL |
| 220016805 | 220006938 | 1.61 | 56.04 | Curative (C) | 2017-11-18 | 2017-11-18 | AML 19 TRIAL | N | N | 220026612 | AML19 TRIAL |
| 220016806 | 220006940 | 1.68 | 91.2 | Disease modification (D) | 2014-12-27 | 2015-03-28 | Trial Unspecified | null | N | 220026614 | TRIAL |
| 220016807 | 220017527 | 1.65 | 0 | Disease modification (D) | 2016-06-16 | 2016-08-10 | Trial Unspecified | null | N | 220026621 | TRIAL |
| 220016808 | 220006943 | 1.71 | 63.4 | Curative (C) | 2013-09-20 | 2013-09-27 | AML 19 TRIAL | 01 | N | 220026626 | AML19 TRIAL |
| 220016809 | 220006947 | 1.62 | 70 | Curative (C) | 2014-07-11 | 2014-07-11 | Trial Unspecified | null | N | 220026636 | TRIAL |
| 220016810 | 220006951 | 1.68 | null | Not known (9) | 2014-07-08 | 2014-07-08 | Cytarabine Low Dose | Y | null | 220026641 | CYTARABINE |
| 220016811 | 220006953 | 1.56 | 12.3 | Disease modification (D) | 2014-05-21 | 2014-05-27 | Quizartinib (AC220) | N | null | 220026663 | NOT MATCHED |
| 220016812 | 220006954 | null | 57.2 | Curative (C) | 2016-01-13 | 2016-04-03 | CYTARABINE + FLUDARABINE + IDARUBICIN + Tretinoin Gemtuzumab Ozogamicin | N | N | 220026665 | NOT MATCHED |
| 220016813 | 220006956 | 1.52 | 43.9 | Palliative (P) | 2019-06-08 | 2019-06-08 | Hydroxycarbamide | N | N | 220026675 | HYDROXYCARBAMIDE |
| 220016814 | 220006958 | null | 15.3 | Palliative (P) | 2016-05-28 | 2016-07-20 | AML Relapsed FLA - Idarubicin | Y | null | 220026681 | NOT MATCHED |
| 220016815 | 220006960 | 1.81 | 65.3 | Palliative (P) | 2012-09-21 | 2013-07-29 | Hydroxycarbamide | Y | N | 220026683 | HYDROXYCARBAMIDE |
| 220016816 | 220006960 | 1.7 | 76 | Palliative (P) | 2018-02-24 | 2018-02-24 | Cytarabine Low Dose | N | null | 220026683 | CYTARABINE |
| 220016817 | 220013834 | 1.7 | 49.2 | Disease modification (D) | 2013-08-19 | 2013-08-19 | Hydroxycarbamide | N | null | 220026693 | HYDROXYCARBAMIDE |
| 220016818 | 220013836 | 1.72 | 69 | Palliative (P) | 2018-04-16 | 2018-08-21 | Hydroxycarbamide | N | N | 220026694 | HYDROXYCARBAMIDE |
| 220016819 | 220006964 | 1.6 | 90.9 | Palliative (P) | 2016-03-01 | 2016-04-04 | AML Downs haM | N | N | 220026698 | NOT MATCHED |
| 220016820 | 220006965 | null | 42 | Curative (C) | 2015-02-05 | 2015-02-18 | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 02 | N | 220026700 | NOT MATCHED |
| 220016821 | 220006966 | 0 | 67 | Palliative (P) | 2017-08-18 | 2017-08-20 | Cytarabine low (10to20mg/m2) IV/SC | 02 | Y | 220026704 | CYTARABINE |
| 220016822 | 220006969 | 0 | 0 | Disease modification (D) | 2014-01-05 | 2014-01-09 | Hydroxycarbamide | N | N | 220026713 | HYDROXYCARBAMIDE |
| 220016823 | 220006971 | 1.63 | 64.4 | Not known (9) | 2015-10-14 | 2016-02-04 | Cytarabine Low Dose | N | N | 220026715 | CYTARABINE |
| 220016824 | 220006973 | 1.44 | null | null | null | 2018-06-12 | Cytarabine low (10to20mg/m2) IV/SC | N | null | 220026721 | CYTARABINE |
| 220016825 | 220019609 | null | 0 | Disease modification (D) | 2017-03-28 | 2017-03-28 | Hydroxycarbamide | N | N | 220026725 | HYDROXYCARBAMIDE |
| 220016826 | 220021864 | null | null | Palliative (P) | 2016-01-18 | 2016-02-21 | AML MyeChild 01 FLA | N | N | 220026730 | NOT MATCHED |
| 220016827 | 220006974 | 1.68 | 86.5 | Curative (C) | 2014-08-22 | 2014-08-22 | Cytarabine low (10to20mg/m2) IV/SC | N | Y | 220026746 | CYTARABINE |
| 220016828 | 220006976 | null | 74 | Curative (C) | 2015-05-20 | 2015-09-26 | null | N | N | 220026760 | NOT MATCHED |
| 220016829 | 220006978 | 1.6 | 9.7 | Palliative (P) | 2016-09-20 | 2016-09-27 | ALL Ph+ve Imatinib alone | 02 | N | 220026762 | NOT MATCHED |
| 220016830 | 220006980 | 1.74 | null | Curative (C) | 2015-12-26 | 2015-12-26 | CYTARABINE | null | null | 220026769 | CYTARABINE |
| 220016831 | 220006981 | 0 | 76.4 | Curative (C) | 2016-03-23 | 2016-04-07 | AML MyeChild 01 FLA-Idarubicin | N | N | 220026769 | NOT MATCHED |
| 220016832 | 220006983 | 1.6 | 12.1 | Curative (C) | 2014-05-22 | 2014-05-22 | Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 220026785 | NOT MATCHED |
| 220016833 | 220017538 | 0 | 30.4 | Palliative (P) | 2016-09-01 | 2016-09-01 | ATG + Cyclophosphamide TBI Allo | 2 | N | 220026790 | NOT MATCHED |
| 220016836 | 220006992 | 0 | null | Curative (C) | 2013-06-01 | 2013-06-07 | AML MyeChild 01 FLA-Idarubicin | 2 | N | 220026806 | NOT MATCHED |
| 220016837 | 220006994 | 1.77 | 30.6 | Curative (C) | 2014-09-16 | 2014-09-17 | Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | Y | N | 220026814 | NOT MATCHED |
| 220016838 | 220006995 | null | 24.6 | Palliative (P) | null | 2016-07-07 | AML MyeChild 01 FLA-Idarubicin | N | N | 220026820 | NOT MATCHED |
| 220016839 | 220006997 | null | 61 | Curative (C) | null | 2013-06-21 | AML MyeChild 01 B Cytarabine/Daunoxome + GO | null | null | 220026826 | NOT MATCHED |
| 220016840 | 220006999 | null | 40 | Curative (C) | 2015-12-06 | 2015-12-06 | Cytarabine Low Dose | 02 | N | 220026833 | CYTARABINE |
| 220016841 | 220007000 | 0 | 81.6 | Palliative (P) | 2013-12-29 | 2014-01-04 | CYTARABINE | N | N | 220026835 | CYTARABINE |
| 220016842 | 220007002 | null | 79.9 | Disease modification (D) | null | 2018-01-18 | Hydroxycarbamide | null | N | 220026836 | HYDROXYCARBAMIDE |
| 220016843 | 220007002 | null | 56.7 | null | 2017-03-07 | 2017-04-22 | Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | 02 | N | 220026836 | NOT MATCHED |
| 220016844 | 220007004 | null | 100.1 | Palliative (P) | null | 2015-05-15 | Cytarabine Low Dose | N | N | 220026839 | CYTARABINE |